Melvin Price v. HHS - Influenza, shoulder injury related to vaccine administration (SIRVA) (2023)
Case summary [AI summaries can sometimes make mistakes]
Melvin Price filed a petition for compensation under the National Vaccine Injury Compensation Program on September 17, 2021. He alleged that he received an influenza vaccine on October 1, 2018, and subsequently suffered a shoulder injury related to vaccine administration (SIRVA), experiencing residual effects for more than six months.
The respondent denied that Mr. Price sustained a SIRVA Table injury, that the vaccine caused his alleged shoulder injury or any other injury, or that his current condition was a sequela of a vaccine-related injury.
Despite these denials, the parties filed a joint stipulation on November 29, 2023, agreeing to settle the case. Chief Special Master Brian H.
Corcoran adopted the stipulation as his decision. Pursuant to the stipulation, Mr.
Price was awarded $14,000.00 as a lump sum, payable by check, representing compensation for all damages available under the program. This amount was a compromise of the parties' respective positions on liability and damages.
The decision does not describe the specific onset of symptoms, medical examinations, diagnostic tests, or treatments. Petitioner was represented by Jeffrey Gordon of Maney & Gordon, P.A., and respondent was represented by James Vincent Lopez of the U.S.
Department of Justice.
Source PDFs
USCOURTS-cofc-1_21-vv-01867